FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

FDA PUBLIC CALENDAR

This public calendar is issued by the Food and Drug Administration. It lists meetings held by the FDA policy makers with persons outside the executive branch of the Federal Government.

	May 2, 2005
FDA Official and Title	Date and Site	Other FDA Participants	Non-FDA Participants	Subject
Jesse L. Goodman, MD, MPH, Director, CBER	4/23/05 Bethesda, MD	Unknown	Representatives of American Society for Reproductive Medicine, and Society for Assisted Reproductive Technology	Discuss industry concerns that new reproductive tissue testing requirements might affect donation
Jesse L. Goodman, MD, MPH, Director, CBER	4/27-29/05 London and Liverpool, UK	Unknown	Representatives of UK Medicines and Healthcare Products Regulator Agency (MHRA) leadership as well as industry senior staff at Chiron Family	Mutual regulatory issues including Chiron remediation activities for flu vaccine manufacturing
Lester Crawford, Acting Commisioner of Food and Drugs	4/25/04 Parklawn, Rockville, MD	Sheldon Bradshaw, Gerald Masoudi, Robert Brackett, Michael Landa, Irene Chan, Linda Katz, Catherine Baily, and Indya Mungo	Pamela Bailey, President, Cosmetic, Toiletry, and Fragrance Association; F. Alan Andersen, Ph.D., Director, Cosmetic Ingredient Review (CIR); and Wilma Berfeld, M.D., Chair, Cosmetic Ingredient Review, Expert Panel	CIR Expert Panel meeting results
Lester Crawford, Acting Commisioner of Food and Drugs	4/26/04 Switzer Building, Washington, DC	Sheila Walcoff, Daniel Schultz, Sheldon Bradshaw, Gerald Masoudi, Susan Bond, and Wanda Russ	Sheridan Group et al. Thomas Sheridan, Suzanne Parison, Sidney Wolfe, Eugene Goldberg, Jane Zones, Cindy Pearson, and William Schultz	To discuss the safety of silicone breast implants
Janet Woodcock, M.D., Deputy Commissioner for Operations	5/2/05 Washington, DC	Steven Galson/ John Jenkins	Henry G. Grabowski/Professor of Economics-Duke University Scott Gottieb- Public Policy Research	2005 Scientific and Regulatory Affairs Section Speaker: The Regulatory Challenges of Balancing Benefit and Risk

Public Calendar Archives
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility

FDA Website Management Staff